Quick Links
Past Events

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 30.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 30.0 Contact Hours.

Mini Symposium: Designated for a maximum of 3.75 AMA PRA Category 1 Credits™ (3.75 Contact Hours)

Main Symposium: Designated for a maximum of 26.25 AMA PRA Category 1 Credits™ (26.25 Contact Hours)

This activity provides Category I CME and self-assessment credits toward Part 2 of the ABS MOC Program. For more information, please visit

Acknowledgment of Commercial Support

This activity is supported by educational grants from AbbVie, Acelity, Astellas, AstraZeneca, Celgene, Eisai Inc., Genentech, Inc., Genomic Health, Inc., Lilly, Novartis Pharmaceuticals Corporation, Pacira Pharmaceuticals, Inc., Pfizer, Puma Biotechnology, Inc, and TESARO, Inc.

For further information concerning Lilly grant funding visit

Privacy Policy
Terms & Conditions
Executive Board
Faculty Portal
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

33rd Annual Miami Breast Cancer Conference®

33rd Annual Miami Breast Cancer Conference®

Friday, March 11, 2016
12:45 PM - 2:00 PM (non-CME Lunch Workshops)
  • Joining Forces for First-Line Treatment of Postmenopausal Women With Estrogen Receptor (ER)-Positive/Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer
    Speaker: Rebecca Lynn Moroose, MD, UF Health Cancer Center at Orlando Health
  • Genomic Assays and Patient Outcomes: What Have We Learned?
    Speaker: Michael Alvarado, MD, Associate Professor of Surgery, UCSF Comprehensive Cancer Center
Saturday, March 12, 2016
12:45 PM - 2:00 PM (non-CME Lunch Workshops)
  • A Paradigm Change in HR+, HER2-Negative Advanced Breast Cancer: Targeted Combination Therapy to Address Endocrine Resistance
    Speaker: Michael Naughton, MD, Assistant Professor of Medicine, Division of Oncology, Washington University School of Medicine, Medical Oncologist, Siteman Cancer Center
  • Updates and Competitive Assessment of Genomic Assays and their Clinical Relevance
    Guest Speaker: James V. Pellicane Jr., MD, FACS


Become a Member

Forgot Password?
Calendar of Events
Filter By